Group 1 - Elutia Inc. (ELUT) is a notable stock in the Medical sector, currently outperforming its peers with a year-to-date gain of 83.3% compared to an average loss of 1.7% in the Medical group [4] - The Medical group consists of 1022 companies and holds a Zacks Sector Rank of 3, indicating strong performance relative to other sectors [2] - Elutia Inc. has a Zacks Rank of 2 (Buy), with its full-year earnings estimate increasing by 42.5% in the past quarter, reflecting improved analyst sentiment [3] Group 2 - Elutia Inc. is part of the Medical - Biomedical and Genetics industry, which includes 502 companies and currently ranks 67 in the Zacks Industry Rank, with the industry experiencing an average loss of 8.8% this year [6] - Adma Biologics (ADMA) is another stock in the Medical sector that has significantly outperformed, with a year-to-date return of 313.1% [4] - Investors should closely monitor Elutia Inc. and Adma Biologics for potential continued strong performance in the Medical sector [7]
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year?